Concurrently elevated CA19.9 and AFP in a radiologically diagnosed PLC, or elevation in a biomarker discordant with the features on the imaging may indicate that the tumor is cHCC-ICC (38–40). The gene discussed is AFP; the disease is intrahepatic cholangiocarcinoma.